Literature DB >> 15134489

Inhibition of anti-apoptotic Bcl-2 family proteins by natural polyphenols: new avenues for cancer chemoprevention and chemotherapy.

Maurizio Pellecchia1, John C Reed.   

Abstract

Amongst the most promising chemopreventive agents, certain natural polyphenols have recently received a great deal of attention from the scientific community, nutritionists, the pharmaceutical industry and the public, due to their demonstrated inhibitory activity against tumorigenesis. In view of their anticancer properties, these compounds also hold great promise as potential chemotherapeutic agents. However, to translate these chemopreventive agents into chemotherapeutic compounds, their exact mechanism of action must be delineated. The aim of this manuscript is to review recent findings suggesting that certain natural products bind and antagonize the anti-apoptotic effects of Bcl-2 family proteins such as Bcl-x(L) and Bcl-2. We will summarize recent studies that were aimed at the identification of the molecular targets of natural polyphenols and at the characterization of their mechanism of action on a molecular level. We will emphasize the importance of these findings that resides not only in the opportunity for the development of novel cancer treatments with these compounds, but also in the structural information that can be used for the design and development of novel and more effective semi-synthetic analogues. The finding reviewed here should encourage the study of possible direct effects of other dietary compounds on Bcl-2 family proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134489     DOI: 10.2174/1381612043384880

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  14 in total

Review 1.  BH3 mimetics to improve cancer therapy; mechanisms and examples.

Authors:  Lin Zhang; Lihua Ming; Jian Yu
Journal:  Drug Resist Updat       Date:  2007-10-24       Impact factor: 18.500

2.  Identification of molecular features necessary for selective inhibition of B cell lymphoma proteins using machine learning techniques.

Authors:  Ahmad Mani-Varnosfaderani; Marzieh Sadat Neiband; Ali Benvidi
Journal:  Mol Divers       Date:  2018-07-12       Impact factor: 2.943

3.  Dextran-catechin conjugate: a potential treatment against the pancreatic ductal adenocarcinoma.

Authors:  Orazio Vittorio; Giuseppe Cirillo; Francesca Iemma; Giovanni Di Turi; Emanuela Jacchetti; Michele Curcio; Serena Barbuti; Niccola Funel; Ortensia Ilaria Parisi; Francesco Puoci; Nevio Picci
Journal:  Pharm Res       Date:  2012-05-24       Impact factor: 4.200

4.  The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.

Authors:  Aslamuzzaman Kazi; Jiazhi Sun; Kenichiro Doi; Shen-Shu Sung; Yoshinori Takahashi; Hang Yin; Johanna M Rodriguez; Jorge Becerril; Norbert Berndt; Andrew D Hamilton; Hong-Gang Wang; Saïd M Sebti
Journal:  J Biol Chem       Date:  2010-12-09       Impact factor: 5.157

5.  Inhibition of Bfl-1 with N-aryl maleimides.

Authors:  John R Cashman; Mary MacDonald; Senait Ghirmai; Karl J Okolotowicz; Eduard Sergienko; Brock Brown; Xochella Garcia; Dayong Zhai; Russell Dahl; John C Reed
Journal:  Bioorg Med Chem Lett       Date:  2010-09-21       Impact factor: 2.823

6.  trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways.

Authors:  G Filomeni; I Graziani; G Rotilio; M R Ciriolo
Journal:  Genes Nutr       Date:  2007-10-18       Impact factor: 5.523

Review 7.  Programmed cell death pathways and current antitumor targets.

Authors:  Mei Lan Tan; Jer Ping Ooi; Nawfal Ismail; Ahmed Ismail Hassan Moad; Tengku Sifzizul Tengku Muhammad
Journal:  Pharm Res       Date:  2009-04-30       Impact factor: 4.200

8.  Structure-based discovery of a new class of Bcl-xL antagonists.

Authors:  Michele F Rega; Marilisa Leone; Dawoon Jung; Naomi J H Cotton; John L Stebbins; Maurizio Pellecchia
Journal:  Bioorg Chem       Date:  2007-05-21       Impact factor: 5.275

9.  Bcl2 family proteins in carcinogenesis and the treatment of cancer.

Authors:  Anna Frenzel; Francesca Grespi; Waldemar Chmelewskij; Andreas Villunger
Journal:  Apoptosis       Date:  2009-04       Impact factor: 4.677

10.  Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21).

Authors:  E Drakos; R R Singh; G Z Rassidakis; E Schlette; J Li; F X Claret; R J Ford; F Vega; L J Medeiros
Journal:  Leukemia       Date:  2011-03-11       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.